Randomized Feasibility Study of S-1 for Adjuvant Chemotherapy in Completely-Resected Stage IA Non-Small-Cell Lung Cancer (SLCG 0701)

被引:0
|
作者
Okumura, Norihito [1 ]
Soh, Junichi [2 ]
Nakata, Masao [3 ]
Nakamura, Hiroshige [4 ]
Fukuda, Minoru [5 ]
Kataoka, Masafumi [6 ]
Kajiwara, Shinsuke [7 ]
Sano, Yoshifumi [8 ]
Aoe, Motoi [9 ]
Kataoka, Kazuhiko [10 ]
Hotta, Katsuyuki [2 ]
Matsuo, Keitaro [11 ]
Toyooka, Shinichi [2 ]
Date, Hiroshi [12 ]
机构
[1] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[4] Tottori Univ, Fac Med, Yonago, Tottori 683, Japan
[5] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[6] Okayama Saiseikai Gen Hosp, Okayama, Japan
[7] Uwajima City Hosp, Uwajima, Japan
[8] Ehime Univ Hosp, Touon, Japan
[9] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[10] Iwakuni Clin Ctr, Iwakuni, Japan
[11] Kyushu Univ, Fac Med Sci, Fukuoka 812, Japan
[12] Kyoto Univ, Grad Sch Med, Kyoto, Japan
关键词
adjuvant chemotherapy; Non-small-cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.02-032
引用
收藏
页码:S440 / S441
页数:2
相关论文
共 50 条
  • [1] Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701
    Soh, Junichi
    Okumura, Norihito
    Nakata, Masao
    Nakamura, Hiroshige
    Fukuda, Minoru
    Kataoka, Masafumi
    Kajiwara, Shinsuke
    Sano, Yoshifumi
    Aoe, Motoi
    Kataoka, Kazuhiko
    Hotta, Katsuyuki
    Matsuo, Keitaro
    Toyooka, Shinichi
    Date, Hiroshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (08) : 741 - 747
  • [2] Feasibility Study of Adjuvant Chemotherapy of S-1 and Carboplatin for Completely Resected Non-Small Cell Lung Cancer
    Komazaki, Yoshitoshi
    Sakashita, Hiroyuki
    Furuiye, Masashi
    Fujie, Toshihide
    Tamaoka, Meiyo
    Sumi, Yuki
    Miyazaki, Yasunari
    Kojima, Katsuo
    Jin, Yasuto
    Inase, Naohiko
    CHEMOTHERAPY, 2013, 59 (01) : 35 - 41
  • [3] FEASIBILITY STUDY OF S-1 ADJUVANT CHEMOTHERAPY IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER
    Okumura, Shunsuke
    Sasaki, Takaaki
    Minami, Yoshinori
    Kitada, Masahiro
    Ohsaki, Yoshinobu
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1327 - S1328
  • [4] Adjuvant Chemotherapy for Completely Resected Non-Small-Cell Lung Cancer
    Suehisa, Hiroshi
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2009, 63 (05) : 223 - 230
  • [5] S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancer
    Okuda, Katsuhiro
    Yano, Motoki
    Tatematsu, Tsutomu
    Nakamae, Katsumi
    Yamada, Takeshi
    Kasugai, Toshio
    Nishida, Tsutomu
    Sano, Masaaki
    Moriyama, Satoru
    Haneda, Hiroshi
    Kawano, Osamu
    Nakanishi, Ryoichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 73 - 79
  • [6] Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
    Okumura, Norihito
    Soh, Junichi
    Suzuki, Hiroyuki
    Nakata, Masao
    Fujiwara, Toshiya
    Nakamura, Hiroshige
    Sonobe, Makoto
    Fujinaga, Takuji
    Kataoka, Kazuhiko
    Gemba, Kenichi
    Kataoka, Masafumi
    Hotta, Katsuyuki
    Yoshioka, Hiroshige
    Matsuo, Keitaro
    Sakamoto, Junichi
    Date, Hiroshi
    Toyooka, Shinichi
    BMC CANCER, 2021, 21 (01)
  • [7] Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
    Norihito Okumura
    Junichi Soh
    Hiroyuki Suzuki
    Masao Nakata
    Toshiya Fujiwara
    Hiroshige Nakamura
    Makoto Sonobe
    Takuji Fujinaga
    Kazuhiko Kataoka
    Kenichi Gemba
    Masafumi Kataoka
    Katsuyuki Hotta
    Hiroshige Yoshioka
    Keitaro Matsuo
    Junichi Sakamoto
    Hiroshi Date
    Shinichi Toyooka
    BMC Cancer, 21
  • [8] Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer
    Funai, Kazuhito
    Takamochi, Kazuya
    Itaya, Toru
    Mochizuki, Takahiro
    Nakamura, Toru
    Toyoda, Futoru
    Yong-Il, Kim
    Sasaki, Kazuyoshi
    Momiki, Shigeru
    Takahashi, Tsuyoshi
    Neyatani, Hiroshi
    Suzuki, Kazuya
    LUNG CANCER, 2010, 68 (01) : 78 - 83
  • [9] Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001
    Norihito Okumura
    Makoto Sonobe
    Kazunori Okabe
    Hiroshige Nakamura
    Masafumi Kataoka
    Motohiro Yamashita
    Masao Nakata
    Kazuhiko Kataoka
    Yoshinori Yamashita
    Junichi Soh
    Hiroshige Yoshioka
    Katsuyuki Hotta
    Keitaro Matsuo
    Junichi Sakamoto
    Shinichi Toyooka
    Hiroshi Date
    International Journal of Clinical Oncology, 2017, 22 : 274 - 282
  • [10] Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001
    Okumura, Norihito
    Sonobe, Makoto
    Okabe, Kazunori
    Nakamura, Hiroshige
    Kataoka, Masafumi
    Yamashita, Motohiro
    Nakata, Masao
    Kataoka, Kazuhiko
    Yamashita, Yoshinori
    Soh, Junichi
    Yoshioka, Hiroshige
    Hotta, Katsuyuki
    Matsuo, Keitaro
    Sakamoto, Junichi
    Toyooka, Shinichi
    Date, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) : 274 - 282